Superior vena cava syndrome caused by an intravascular thrombosis due to underlying prostate carcinoma.

Superior Vena Cava Syndrome due to Thrombosis: A Rare Paraneoplastic Presentation of Bronchogenic Carcinoma

Superior vena cava (SVC) syndrome is not an uncommon occurrence in patients with malignancy and it is often described as a medical emergency. In majority of the cases, SVC syndrome occurs due to mechanical obstruction of the SVC by extraluminal compression with primary intrathoracic malignancies. However, intraluminal obstruction due to thrombosis can also produce symptoms and signs of SVC synd...

Antiphospholipid Syndrome Presenting with Superior Vena Cava Thrombosis

Superior Vena Cava Thrombosis in a Case of Lung Adenocarcinoma

♦Corresponding Author: Kaushik Saha, MD Rabindra Pally, 1st Lane, P.O. Nimta, Kolkata – 700049, West Bengal, India Tel: +919433383080, +91033-25396689 Email: [email protected] Introduction Superior vena cava (SVC) thrombosis is a common phenomenon secondary to subclavian catheterization, however in malignancy it is quite uncommon. Pure intravascular thrombosis is extremely rare and on...

Mediastinal Neuroendocrine Carcinoma of Unknown Origin Presenting with Superior Vena Cava Syndrome (SVCS): A Case Report

Primary neuroendocrine carcinoma (NEC) of the mediastinum is a rare type of carcinoma. According to the literature, only five cases of this condition have been reported so far. In this paper, we present a rare case of mediastinal NEC of unknown primary site. The patient was a 34-year-old man with mediastinal NEC, who presented with chronic dry cough and a right-sided mediastinal mass one year p...

Non-small Cell Lung Cancer with Superior Vena Cava Syndrome Effectively Treated with Implantation of Intravascular Stent and Chemotherapy A Case Report and Review of the Literature

Superior vena cava syndrome is caused by obstruction of the superior vena cava due to a variety of malignant and benign entities. The most common malignant entities are lung cancer and mediastinal tumor. Conventional treatments include bypass surgery, external beam radiation therapy, chemotherapy, and medical treatment. In this report, we performed an intravascular metallic stent deployment and...